Earticle

초록

영어

Objectives : The aim of this study was to investigate the effect of various Republic of Korea policies, including the medicine cost rationalization policy implemented By investigating the management strategy/performance changes of the industry caused by such policies. Methods : Pharmaceutical companies listed on the national stock exchange and the KOSDAQ were examined for 10 years from 2004 to 2013. Their financial statements were collected and market changes before and after drug price policy implementations were compared. Results : From the result of this research, among the medicine related policies, the drug price rationalization policy was found to have a significant effect on business management strategies in terms of safety, profitability and growth potential after its implementation. After the drug pricing transparency policy was implemented, management strategies were affected significantly in terms of safety and profitability. Conclusions : As a result, all of the medicine related policies were found to have regulatory effects. Based on these findings, implications, research limitations and future study plans are presented.

목차

Abstract
 Ⅰ. 서론
 Ⅱ. 연구방법
  1. 연구대상 및 기간
  2. 연구모형
  3. 변수의 조작적 정의
  4. 자료 분석 방법
 Ⅲ. 연구결과
  1. 주요항목의 평균과 표준편차, 년도별 변화량
  2. 의약품 관련 정책하에서 경영전략변수가 경영성과변수에 미치는 영향분석
  3. 의약품관련정책의 조절효과분석
 Ⅳ. 고찰
 Ⅴ. 결론
 REFERENCES

키워드

저자

• 정재훈 [ Jae-Hoon Jung | 부산대학교대학원 의료산업학과 ]
• 조덕영 [ Duk-Young Cho | 부산대학교 의학전문대학원 ] Corresponding author
• 최수형 [ Suhe-yong Choi | 부산대학교 경영학과 ]

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  보건의료산업학회지 [The Korean Journal of Health Service Management]

• 간기

  계간

• pISSN

  2093-5986

• 수록기간

  2007~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 517 DDC 613